ASCO 2020: BCMA CAR-T Race Heats Up Between Bristol And Janssen

 
• By Mandy Jackson
T cell lymphocyte with receptors to kill cancer cell in cancer immunotherapy 3D render
CAR-T cells targeting BCMA induce high responses in heavily pre-treated myeloma • Source: Shutterstock

More from ASCO

More from Conferences